Abstract

Vaccination during pregnancy is a safe and effective intervention to protect women from potentially severe consequences of influenza and reduce risk of influenza and pertussis in their infants. However, coverage remains variable. In this mini-review we update findings from a 2015 systematic review to describe results from recent studies in high income countries on the uptake of influenza and pertussis vaccination in pregnancy, reasons for vaccine hesitancy and barriers to increasing uptake, from maternal and healthcare provider (HCP) perspectives. Studies reported highly variable uptake (from 0% to 78%). A main facilitator for uptake among pregnant women was receiving a recommendation from their HCP. However, studies showed that HCP awareness of guidelines did not consistently translate into them recommending vaccines to pregnant women. Safety concerns are a well-established barrier to uptake/coverage of maternal immunization; 7%-52% of unvaccinated women gave safety concerns as a reason but these were also present in vaccinated women. Knowledge/awareness gaps among pregnant women and lack of confidence among HCPs to discuss vaccination were both important barriers. Several studies indicated that midwives were more likely to express safety concerns than other HCPs, and less likely to recommend vaccination to pregnant women. Women who perceived the risk of infection to be low were less likely to accept vaccination in several studies, along with women with prior vaccine refusal. Findings highlight the importance of further research to explore context-specific barriers to vaccination in pregnancy, which may include lack of vaccine confidence among pregnant woman and HCPs, and policy and structural factors.

Highlights

  • Vaccination in pregnancy was first implemented in the 1960s with tetanus toxoid immunization, with strategies of maternal immunization to protect pregnant women and their infants against influenza and pertussis more recently introduced

  • A systematic review on vaccine acceptance in pregnancy in 2015 found that concern about vaccine safety was the main factor contributing to vaccine hesitancy, with other common barriers being lack of recommendation from health care providers (HCPs) and poor vaccine knowledge [13]

  • Our aim is to update these findings with recent studies conducted in high income countries (HICs) in order to describe the uptake of influenza and pertussis vaccination in pregnancy, explore reasons for vaccine hesitancy and discuss barriers to increasing uptake, from maternal and HCP perspectives

Read more

Summary

Barriers and Facilitators Associated With Vaccine Acceptance and Uptake

Among Pregnant Women in High Income Countries: A Mini-Review. Vaccination during pregnancy is a safe and effective intervention to protect women from potentially severe consequences of influenza and reduce risk of influenza and pertussis in their infants. In this mini-review we update findings from a 2015 systematic review to describe results from recent studies in high income countries on the uptake of influenza and pertussis vaccination in pregnancy, reasons for vaccine hesitancy and barriers to increasing uptake, from maternal and healthcare provider (HCP) perspectives. Safety concerns are a well-established barrier to uptake/coverage of maternal immunization; 7%52% of unvaccinated women gave safety concerns as a reason but these were present in vaccinated women. Knowledge/awareness gaps among pregnant women and lack of confidence among HCPs to discuss vaccination were both important barriers. Findings highlight the importance of further research to explore context-specific barriers to vaccination in pregnancy, which may include lack of vaccine confidence among pregnant woman and HCPs, and policy and structural factors

INTRODUCTION
UPTAKE OF INFLUENZA AND PERTUSSIS VACCINATION IN PREGNANCY
INFLUENCE OF HCP OFFER AND RECOMMENDATION
Germany National
SAFETY CONCERNS AS A BARRIER TO UPTAKE
Influenza or Pertussis
Findings
OTHER FACTORS INFLUENCING ACCEPTANCE
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call